Single-incision laparoscopic colectomy for malignant disease.

Area of Science:

• Colorectal Surgery
• Minimally Invasive Surgery
• Surgical Oncology

Background:

• Laparoscopic colectomy provides survival benefits comparable to open colectomy.
• Patients undergoing laparoscopic colectomy experience shorter hospital stays and reduced narcotic use.
• Single-incision laparoscopic colectomy (SIL-C) may offer enhanced benefits over traditional laparoscopic colectomy without compromising oncologic outcomes.

Purpose of the Study:

• To evaluate the safety and efficacy of SIL-C compared to traditional laparoscopic colectomy (TLC).
• To assess oncologic principles, operative outcomes, and postoperative recovery between SIL-C and TLC.

Main Methods:

• Retrospective review of patient records undergoing SIL-C or TLC for malignant or potentially malignant colorectal disease.
• SIL-C utilized a single-port access device with a standard lateral-to-medial laparoscopic technique.
• Forty-six TLC patients from the preceding year served as controls for 27 SIL-C procedures.

Main Results:

• No significant differences in median operative time, blood loss, or lymph node yield between SIL-C and TLC groups.
• SIL-C group showed a trend towards shorter median length of stay (3 days vs. 5 days, p=0.079).
• Fewer postoperative complications (5 vs. 16) and no deaths were observed in the SIL-C group compared to TLC.

Conclusions:

• SIL-C is a safe and feasible option for selected colon cancer patients.
• The technique achieves comparable oncologic outcomes to TLC, with potential for reduced hospital stay.
• SIL-C may represent an advancement in minimally invasive colorectal surgery.